{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:08:35Z","timestamp":1791947315297,"version":"4.3.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rheumatoid arthritis (RA) is an inflammatory autoimmune joint disease in which the complement system plays an important role. Of the several components of complement, current evidence points to C5 as the most important inducer of inflammation. Several groups generated Abs or small interfering RNAs (siRNAs) or small molecule inhibitors against C5 and C5aR1 (CD88) that have showed some efficacy in RA in animal models. However, none of these candidate therapeutics has moved from bench to bedside. In this study, we test in collagen Ab-induced arthritis (CAIA) a new therapeutic strategy using a novel anti\u2013C5ab-C5 siRNA conjugate. We first demonstrate that although C5aR2 or C5L2 (GPR77) plays no role in CAIA, C5aR1 contributes to pathogenesis. We demonstrate that injection of siRNAs blocking C5, C5aR1, or the combination decreased clinical disease activity in mice with CAIA by 45%, 51%, and 58%, respectively. Anti-C5 Ab (BB5.1) has only limited efficacy, but significantly reduced arthritis up to 66%. We then generated a novel anti-C5aR1 Ab\u2013protamine\u2013C5 siRNA conjugate. To our knowledge, we show for the first time that whereas unconjugated Ab plus siRNAs reduce arthritis by 19%, our anti-C5aR1 Ab\u2013protamine\u2013C5 siRNA conjugate was effective in reducing arthritis by 83% along with a parallel decrease in histopathology, C3 deposition, neutrophils, and macrophages in the joints of mice with CAIA. These data suggest that by targeting anti-C5 siRNAs to the receptor for its C5a activation fragment (C5aR1), a striking clinical effect can be realized.<\/jats:p>","DOI":"10.4049\/jimmunol.1403012","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T01:41:13Z","timestamp":1430185273000},"page":"5446-5454","source":"Crossref","is-referenced-by-count":54,"title":["A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA"],"prefix":"10.1093","volume":"194","author":[{"given":"Gaurav","family":"Mehta","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus , Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I","family":"Scheinman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado, Anschutz Medical Campus , Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V Michael","family":"Holers","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus , Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal K","family":"Banda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus , Aurora, CO 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"2025030706364787100_r1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","article-title":"Complement and autoimmunity","volume":"56","author":"Ballanti","year":"2013","journal-title":"Immunol. Res."},{"key":"2025030706364787100_r2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5-C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Mol. Immunol."},{"key":"2025030706364787100_r3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"Banda","year":"2012","journal-title":"J. Immunol."},{"key":"2025030706364787100_r4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"2025030706364787100_r5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1567-5769(00)00038-2","article-title":"Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells","volume":"1","author":"Schieferdecker","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"2025030706364787100_r6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1096\/fj.12-220509","article-title":"C5L2: a controversial receptor of complement anaphylatoxin, C5a","volume":"27","author":"Li","year":"2013","journal-title":"FASEB J."},{"key":"2025030706364787100_r7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2014.07.004","article-title":"Complement nomenclature 2014","volume":"61","author":"Kemper","year":"2014","journal-title":"Mol. Immunol."},{"key":"2025030706364787100_r8","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.92.19.8955","article-title":"Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030706364787100_r9","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1371\/journal.pone.0013511","article-title":"A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis","volume":"5","author":"Nandakumar","year":"2010","journal-title":"PLoS ONE"},{"key":"2025030706364787100_r10","first-page":"191","article-title":"T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse","volume":"73","author":"Andersson","year":"1991","journal-title":"Immunology"},{"key":"2025030706364787100_r11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.4049\/jimmunol.142.7.2237","article-title":"Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice","volume":"142","author":"Banerjee","year":"1989","journal-title":"J. Immunol."},{"key":"2025030706364787100_r12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00212308","article-title":"The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis","volume":"34","author":"Spinella","year":"1991","journal-title":"Immunogenetics"},{"key":"2025030706364787100_r13","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.34430","article-title":"Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5","volume":"64","author":"Macor","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2025030706364787100_r14","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/art.10591","article-title":"Mechanisms of effects of complement inhibition in murine collagen-induced arthritis","volume":"46","author":"Banda","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2025030706364787100_r15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2009.04035.x","article-title":"Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro","volume":"159","author":"Banda","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"2025030706364787100_r16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"Neumann","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2025030706364787100_r17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00296-002-0199-6","article-title":"Expression of the anaphylatoxin receptor C5aR (CD88) by human articular chondrocytes","volume":"22","author":"Onuma","year":"2002","journal-title":"Rheumatol. Int."},{"key":"2025030706364787100_r18","first-page":"1408","article-title":"Expression of C5aR (CD88) of synoviocytes isolated from patients with rheumatoid arthritis and osteoarthritis","volume":"116","author":"Yuan","year":"2003","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2025030706364787100_r19","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2005-02-0564","article-title":"Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"key":"2025030706364787100_r20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation","volume":"46","author":"Vergunst","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025030706364787100_r21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrrheum.2012.176","article-title":"siRNA-based therapeutic approaches for rheumatic diseases","volume":"9","author":"Apparailly","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2025030706364787100_r22","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1016\/j.biomaterials.2013.04.060","article-title":"A review of the current status of siRNA nanomedicines in the treatment of cancer","volume":"34","author":"Resnier","year":"2013","journal-title":"Biomaterials"},{"key":"2025030706364787100_r23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/gt.2011.149","article-title":"Current progress in the development of RNAi-based therapeutics for HIV-1","volume":"18","author":"Zhou","year":"2011","journal-title":"Gene Ther."},{"key":"2025030706364787100_r24","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2217\/nnm.11.90","article-title":"Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model","volume":"6","author":"Scheinman","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"2025030706364787100_r25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","article-title":"Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors","volume":"23","author":"Song","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"2025030706364787100_r26","doi-asserted-by":"crossref","first-page":"130ra148","DOI":"10.1126\/scitranslmed.3003601","article-title":"Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis","volume":"4","author":"Yao","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"2025030706364787100_r27","doi-asserted-by":"crossref","first-page":"e9463","DOI":"10.1371\/journal.pone.0009463","article-title":"Novel siRNA delivery system to target podocytes in vivo","volume":"5","author":"Hauser","year":"2010","journal-title":"PLoS ONE"},{"key":"2025030706364787100_r28","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.173.5.3437","article-title":"C5a initiates the inflammatory cascade in immune complex peritonitis","volume":"173","author":"Godau","year":"2004","journal-title":"J. Immunol."},{"key":"2025030706364787100_r29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.110.954370","article-title":"C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice","volume":"122","author":"Shagdarsuren","year":"2010","journal-title":"Circulation"},{"key":"2025030706364787100_r30","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI16577","article-title":"C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease","volume":"110","author":"Shushakova","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2025030706364787100_r31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-2478(03)00052-X","article-title":"Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody","volume":"88","author":"Soruri","year":"2003","journal-title":"Immunol. Lett."},{"key":"2025030706364787100_r32","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.4049\/jimmunol.1301626","article-title":"Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis","volume":"191","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"2025030706364787100_r33","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.1400752","article-title":"Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression","volume":"193","author":"Banda","year":"2014","journal-title":"J. Immunol."},{"key":"2025030706364787100_r34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"2025030706364787100_r35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12967-014-0285-z","article-title":"Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNF\u03b1 in rheumatoid arthritis","volume":"12","author":"Moore","year":"2014","journal-title":"J. Transl. Med."},{"key":"2025030706364787100_r36","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.177.3.1904","article-title":"Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis","volume":"177","author":"Banda","year":"2006","journal-title":"J. Immunol."},{"key":"2025030706364787100_r37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.1400752","article-title":"Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression","volume":"193","author":"Banda","year":"2014","journal-title":"J. Immunol."},{"key":"2025030706364787100_r38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0161-5890(00)00067-5","article-title":"A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells","volume":"37","author":"Ohno","year":"2000","journal-title":"Mol. Immunol."},{"key":"2025030706364787100_r39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12338","article-title":"Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model","volume":"177","author":"Andersson","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"2025030706364787100_r40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/0929867053363379","article-title":"Targeting C5a: recent advances in drug discovery","volume":"12","author":"Allegretti","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"2025030706364787100_r41","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1021\/bi702321a","article-title":"Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor","volume":"47","author":"Nikiforovich","year":"2008","journal-title":"Biochemistry"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/11\/5446\/62234303\/1403012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/11\/5446\/62234303\/1403012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:29:48Z","timestamp":1741332588000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/194\/11\/5446\/7973192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1403012","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,6,1]]}}}